Blood Research

Download original image

Key results from phase III trials comparing NOACs to warfarin for stroke prevention in AF.

a)Includes additional events identified post-publication, which did not alter conclusions. b)Per-protocol, as-treated population.

Abbreviations: BID, twice daily; OD, once daily; AF, atrial fibrillation; SE, systemic embolism.

Blood Res 2016;51:77~87 https://doi.org/10.5045/br.2016.51.2.77
© Blood Research
© 2024. BLOOD RESEARCH All rights reserved. Powered by INFOrang Co., Ltd